Incyte Corp. (INCY) Shares Down Despite Recent Market Volatility

Incyte Corp. (NASDAQ: INCY)’s stock price has decreased by -0.52 compared to its previous closing price of 51.92. However, the company has seen a -2.95% decrease in its stock price over the last five trading sessions. Zacks Investment Research reported 2024-04-23 that Incyte (INCY) doesn’t possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Is It Worth Investing in Incyte Corp. (NASDAQ: INCY) Right Now?

Incyte Corp. (NASDAQ: INCY) has a price-to-earnings ratio of 19.53x that is above its average ratio. Additionally, the 36-month beta value for INCY is 0.69. There are mixed opinions on the stock, with 12 analysts rating it as a “buy,” 5 rating it as “overweight,” 4 rating it as “hold,” and 0 rating it as “sell.”

The public float for INCY is 221.84M and currently, short sellers hold a 3.63% ratio of that float. The average trading volume of INCY on April 24, 2024 was 1.72M shares.

INCY’s Market Performance

INCY stock saw a decrease of -2.95% in the past week, with a monthly decline of -9.35% and a quarterly a decrease of -16.52%. The volatility ratio for the week is 1.75%, and the volatility levels for the last 30 days are 1.88% for Incyte Corp. (INCY). The simple moving average for the last 20 days is -5.81% for INCY stock, with a simple moving average of -13.02% for the last 200 days.

Analysts’ Opinion of INCY

Jefferies, on the other hand, stated in their research note that they expect to see INCY reach a price target of $81. The rating they have provided for INCY stocks is “Buy” according to the report published on February 23rd, 2024.

INCY Trading at -9.94% from the 50-Day Moving Average

After a stumble in the market that brought INCY to its low price for the period of the last 52 weeks, the company was unable to rebound, for now settling with -31.81% of loss for the given period.

Volatility was left at 1.88%, however, over the last 30 days, the volatility rate increased by 1.75%, as shares sank -10.14% for the moving average over the last 20 days. Over the last 50 days, in opposition, the stock is trading -10.42% lower at present.

During the last 5 trading sessions, INCY fell by -2.95%, which changed the moving average for the period of 200-days by -16.79% in comparison to the 20-day moving average, which settled at $54.54. In addition, Incyte Corp. saw -17.74% in overturn over a single year, with a tendency to cut further losses.

Insider Trading

Reports are indicating that there were more than several insider trading activities at INCY starting from Stein Steven H, who sale 7,365 shares at the price of $65.51 back on Jan 03 ’24. After this action, Stein Steven H now owns 90,218 shares of Incyte Corp., valued at $482,481 using the latest closing price.

Iyengar Vijay K, the EVP, GMAPPS of Incyte Corp., sale 657 shares at $65.00 during a trade that took place back on Jan 02 ’24, which means that Iyengar Vijay K is holding 43,412 shares at $42,705 based on the most recent closing price.

Stock Fundamentals for INCY

Current profitability levels for the company are sitting at:

  • 0.19 for the present operating margin
  • 0.93 for the gross margin

The net margin for Incyte Corp. stands at 0.16. The total capital return value is set at 0.12. Equity return is now at value 12.50, with 9.41 for asset returns.

Based on Incyte Corp. (INCY), the company’s capital structure generated 0.01 points at debt to capital in total, while cash flow to debt ratio is standing at 12.97. The debt to equity ratio resting at 0.01. The interest coverage ratio of the stock is 269.0.

Currently, EBITDA for the company is 904.74 million with net debt to EBITDA at -3.67. When we switch over and look at the enterprise to sales, we see a ratio of 2.28. The receivables turnover for the company is 4.97for trailing twelve months and the total asset turnover is 0.54. The liquidity ratio also appears to be rather interesting for investors as it stands at 3.75.

Conclusion

In conclusion, Incyte Corp. (INCY) has seen bad performance in recent times. Analysts have a mixed opinion on the stock, with some rating it as a “buy” and others rating it as a “hold”. It’s important to note that the stock is currently trading at a significant distance from its 50-day moving average and its 52-week high.

Most Popular

Related Posts